252 related articles for article (PubMed ID: 2429859)
1. Striato-nigral dynorphin and substance P pathways in the rat. II. Functional analysis.
Herrera-Marschitz M; Christensson-Nylander I; Sharp T; Staines W; Reid M; Hökfelt T; Terenius L; Ungerstedt U
Exp Brain Res; 1986; 64(1):193-207. PubMed ID: 2429859
[TBL] [Abstract][Full Text] [Related]
2. Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies.
Christensson-Nylander I; Herrera-Marschitz M; Staines W; Hökfelt T; Terenius L; Ungerstedt U; Cuello C; Oertel WH; Goldstein M
Exp Brain Res; 1986; 64(1):169-92. PubMed ID: 2429858
[TBL] [Abstract][Full Text] [Related]
3. Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms.
Reid MS; Herrera-Marschitz M; Hökfelt T; Lindefors N; Persson H; Ungerstedt U
Exp Brain Res; 1990; 82(2):293-303. PubMed ID: 1704847
[TBL] [Abstract][Full Text] [Related]
4. Dopamine receptors mediate alterations in striato-nigral dynorphin and substance P pathways.
Nylander I; Terenius LH
Neuropharmacology; 1987 Sep; 26(9):1295-302. PubMed ID: 2444900
[TBL] [Abstract][Full Text] [Related]
5. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--II. Effects of dopamine D1 and D2 receptor agonists.
You ZB; Herrera-Marschitz M; Nylander I; Goiny M; O'Connor WT; Ungerstedt U; Terenius L
Neuroscience; 1994 Nov; 63(2):427-34. PubMed ID: 7891856
[TBL] [Abstract][Full Text] [Related]
6. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--I. Effects of K(+)-depolarization, lesions and peptidase inhibition.
You ZB; Nylander I; Herrera-Marschitz M; O'Connor WT; Goiny M; Terenius L
Neuroscience; 1994 Nov; 63(2):415-25. PubMed ID: 7891855
[TBL] [Abstract][Full Text] [Related]
7. Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats.
Pollack AE; Turgeon SM; Fink JS
Neuroscience; 1997 Jul; 79(1):79-93. PubMed ID: 9178866
[TBL] [Abstract][Full Text] [Related]
8. Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral delivery.
Lapchak PA; Miller PJ; Collins F; Jiao S
Neuroscience; 1997 May; 78(1):61-72. PubMed ID: 9135089
[TBL] [Abstract][Full Text] [Related]
9. The dopamine-gamma aminobutyric acid interaction in the striatum of the rat is differently regulated by dopamine D-1 and D-2 types of receptor: evidence obtained with rotational behavioural experiments.
Herrera-Marschitz M; Ungerstedt U
Acta Physiol Scand; 1987 Mar; 129(3):371-80. PubMed ID: 3033996
[TBL] [Abstract][Full Text] [Related]
10. Intranigral injection of dynorphin in combination with substance P on striatal dopamine metabolism in the rat.
Tan DP; Tsou K
Brain Res; 1988 Mar; 443(1-2):310-4. PubMed ID: 2451993
[TBL] [Abstract][Full Text] [Related]
11. Basal ganglia outflow pathways and circling behaviour in the rat.
Leigh PN; Reavill C; Jenner P; Marsden CD
J Neural Transm; 1983; 58(1-2):1-41. PubMed ID: 6418859
[TBL] [Abstract][Full Text] [Related]
12. Effects of intranigral substance P and neurokinin A on striatal dopamine release--I. Interactions with substance P antagonists.
Reid MS; Herrera-Marschitz M; Hökfelt T; Ohlin M; Valentino KL; Ungerstedt U
Neuroscience; 1990; 36(3):643-58. PubMed ID: 1700329
[TBL] [Abstract][Full Text] [Related]
13. Effect of intranigral injections of dynorphin, dynorphin fragments and alpha-neoendorphin on rotational behaviour in the rat.
Herrera-Marschitz M; Hökfelt T; Ungerstedt U; Terenius L; Goldstein M
Eur J Pharmacol; 1984 Jul; 102(2):213-27. PubMed ID: 6148248
[TBL] [Abstract][Full Text] [Related]
14. Differential modulation of striatal dopamine release by intranigral injection of gamma-aminobutyric acid (GABA), dynorphin A and substance P.
Reid M; Herrera-Marschitz M; Hökfelt T; Terenius L; Ungerstedt U
Eur J Pharmacol; 1988 Mar; 147(3):411-20. PubMed ID: 2454197
[TBL] [Abstract][Full Text] [Related]
15. Reconstruction of the striato-nigro-striatal circuitry by simultaneous double dopaminergic grafts: a tracer study using fluorogold and horseradish peroxidase.
Mendez I; Hong M
Brain Res; 1997 Dec; 778(1):194-205. PubMed ID: 9462892
[TBL] [Abstract][Full Text] [Related]
16. Functional studies with the opioid peptide dynorphin: acute effects of injections into the substantia nigra reticulata of naive rats.
Herrera-Marschitz M; Hökfelt T; Ungerstedt U; Terenius L
Life Sci; 1983; 33 Suppl 1():555-8. PubMed ID: 6141500
[TBL] [Abstract][Full Text] [Related]
17. Bilateral cerebral metabolic effects of pharmacological manipulation of the substantia nigra in the rat: unilateral intranigral application of the putative excitatory neurotransmitter substance P.
Dermon CR; Tzagournissakis M; Savaki HE
Neuroscience; 1992 Oct; 50(4):795-809. PubMed ID: 1280349
[TBL] [Abstract][Full Text] [Related]
18. Opposite effects of intranigral ibotenic acid and 6-hydroxydopamine on motor behavior and on striatal neuropeptide Y neurons.
Nitsch C; Wolfrum G; Schaefer F; Scotti AL; Unger J
Brain Res Bull; 1993; 30(1-2):21-32. PubMed ID: 8420631
[TBL] [Abstract][Full Text] [Related]
19. Autoregulation of dopamine release and metabolism by intrastriatal nigral grafts as revealed by intracerebral dialysis.
Strecker RE; Sharp T; Brundin P; Zetterström T; Ungerstedt U; Björklund A
Neuroscience; 1987 Jul; 22(1):169-78. PubMed ID: 2819773
[TBL] [Abstract][Full Text] [Related]
20. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat--II. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor function.
Morari M; O'Connor WT; Ungerstedt U; Bianchi C; Fuxe K
Neuroscience; 1996 May; 72(1):89-97. PubMed ID: 8730708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
